ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
US Tech 100
17,065.60
0.37%
Dow Jones
38,460.92
-0.11%
Brent Oil
87.185
-0.43%
Bitcoin
63,882.56
-3.81%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Omnicell Inc (OMCL) Quote

Omnicell Inc

Omnicell Inc (OMCL)

NASDAQ
27.43
-1.00
(-3.52%)
At close: April 24 4:00PM
Delayed by 15 minutes
27.43
-1.00
( -3.52% )
After Hours: 4:02PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
27.43
Bid
26.78
Ask
28.91
Volume
444,222
27.07 Day's Range 28.35
25.69 52 Week Range 77.135
Market Cap
1.262B
Previous Close
28.43
Open
28.22
Last Trade
1
@
27.43
Last Trade Time
16:02:01
Financial Volume
$ 12,196,095
VWAP
27.455
Average Volume (3m)
574,716
Shares Outstanding
45,915,296
Dividend Yield
-
PE Ratio
-61.93
Earnings Per Share (EPS)
-0.44
Revenue
1.15B
Net Profit
-20.37M

About Omnicell Inc

Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medicat... Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States. Show more

Sector
Electronic Computers
Industry
Electronic Computers
Website
www.omnicell.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Omnicell Inc is listed in the Electronic Computers sector of the NASDAQ with ticker OMCL. The last closing price for Omnicell was $28.43. Over the last year, Omnicell shares have traded in a share price range of $ 25.69 to $ 77.135.

Omnicell currently has 45,915,296 shares outstanding. The market capitalization of Omnicell is $1.26 billion. Omnicell has a price to earnings ratio (PE ratio) of -61.93.

OMCL Latest News

More News

Omnicell Announces XT Amplify

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the...

April 16 2024
Business Wire

Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2...

April 08 2024
Business Wire

Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March...

March 11 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 16 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.572.1221146686526.8629.3126.1439132627.62106312CS
4-0.8-2.8338646829628.2329.70526.1438737027.79771735CS
12-5.01-15.443896424232.4433.325.6957471628.30784727CS
26-10.94-28.511858222638.3739.9825.6960869231.66793363CS
52-34.82-55.935742971962.2577.13525.6956845844.81886678CS
156-112.65-80.4183323815140.08187.28525.6947568880.6956844CS
260-47.86-63.567538849875.29187.28525.6942234683.0126046CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

Discussion

View Full Feed
Agoura Guy Agoura Guy 3 minutes ago
META $439.83 -53.67 (-10.88%) FANBOYS GOT ***ZUCKED***!!!!!!!!!!!!!

ROTFLMAO!!!!!!!!!!

META
moe_the_gyp01 moe_the_gyp01 3 minutes ago
https://www.investopedia.com/meta-shares-fall-after-executives-highlight-a-volatile-macro-environment-8382862

The AI narrative is still alive and well.

Executives and analysts remain optimistic, citing strong business fundamentals and advertiser demand, along with oppor
META
mfaphoto mfaphoto 3 minutes ago
As Dr. Franstein said of his creation. "It's Alive! It's Alive".
NSAV
tw0122 tw0122 3 minutes ago
ACRV $12 + 27% look for $12.10- $14.09
ACRV
gorbec1 gorbec1 4 minutes ago
Better than I am I couldn’t stick to anything that long
MCIC
Barron4664 Barron4664 4 minutes ago
The reason you do not understand is because you fail to understand. The answer to why the Supremes and every other court for that matter ruled the way they did has been answered in my posts for a couple years now. You have eyes. Go read them. The plaintiff attorneys have corruptly conspired to obfu
FNMA
$on_myMind $on_myMind 4 minutes ago
https://twitter.com/ldev117/status/1783207682448802132
TAER
Dingster Dingster 4 minutes ago
TRUTH GIFA FILES ANOTHER YEAR WITH NEVADA
https://www.nvsilverflume.gov/home
Entity Name:GIFA, INC.Entity Number:E0276552008-9
Entity Type:Domestic Corporation (78)Entity Status:Active
FILING HISTORY DETAILS
File Date Effective Date Filing Number Document Type Amen
GIFX
Lockman Lockman 4 minutes ago
Ya had that run around 3:00 and fell off table after hours lol
SPY
Topgun21 Topgun21 4 minutes ago
Come come GOLDEN CROSS!
CEO delivers any BLOCKBUSTER news with the technicals like they are... this will THERMO NUCLEAR EXPLODE to COPPER in a New York minute!
AMAZING float that looks LOCKED!

Love that spread sharky at the end 28 x 34 BWAHH!!

LOCKED FLOA
BLEG
oldman69 oldman69 4 minutes ago
What stock is that?
IQST
georgie18 georgie18 4 minutes ago
ROMA...7988...Hopefully we get more of the same tomorrow...🥳

georgie18

Member Level
Re: georgie18 post# 641117

Wednesday, April 24, 2024 3:50:50 PM

Post#
641150
of 641161
ROMA...782s clearing here at H
crazyjogger925 crazyjogger925 4 minutes ago
true many of these pinkies have an o/s 6-7 billion shares and they get a good following too.pacv unrestricted o/s as of this monday 26,121,788
PACV
Natural Trader Natural Trader 4 minutes ago
VERB is cash positive ; As further set forth in the Form 10-K, the Company disclosed that it had cash and cash equivalents of approximately $14.2 million and notes payable of approximately $1.2 million. This represents an increase in cash and cash equivalents of $10.9 million and a decrease in notes
Monksdream Monksdream 5 minutes ago
As one can observe the price discovery bounced off a 52 week low
Will it trend north for a couple few trading sessions
Maybe Wainwright will PR a price target

https://investorshub.advfn.com/uimage/uploads/2024/4/24/sgtnpIMG_7685.gif
AMST
Xman1959 Xman1959 5 minutes ago
did you see that "Earl Scheib" paint job? 99.99 special lol
SPZI
bunda bunda 5 minutes ago
lol. ty happy traiding
IGPK
jxyzobrien jxyzobrien 5 minutes ago
earnings are crazy
meta expenses bad

i was out of nq .
PennyStockTrader2 PennyStockTrader2 5 minutes ago
not me, I did have an order in but after the spike down to .008x
MRGE
Natural Trader Natural Trader 5 minutes ago
VERB is cash positive ; As further set forth in the Form 10-K, the Company disclosed that it had cash and cash equivalents of approximately $14.2 million and notes payable of approximately $1.2 million. This represents an increase in cash and cash equivalents of $10.9 million and a decrease in notes
bambam56 bambam56 5 minutes ago
Correct , thankyou
JAGX
Chiugray Chiugray 5 minutes ago
Shorts short to keep the price down, so their mark-to-market naked/legal short liabilities don't blow up in their face. It will blow up on them regardless, very soon, and upon approval, but the shorts are trying to manage that. That is the basic premise. Your response of why shorts would continue to
NWBO
surfkast surfkast 5 minutes ago
LOL!
BNGI
AngeloFoca AngeloFoca 5 minutes ago
So... My post got one (1) legitimate response and FOUR (4) fudster comments.

Yes, 7 years but there's a rumor that the 8th time is a charmer.





.
NWBO

Your Recent History

NASDAQ
OMCL
Omnicell
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved